MedPath

Efficacy of STELARA (ustekinumab) with ulcerative colitis: multicenter prospective observational study -KDOG UC-UST STUDY

Not Applicable
Conditions
ulcerative colitis
Registration Number
JPRN-UMIN000041774
Lead Sponsor
Kitasato University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
31
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients participating in clinical trials of other new drugs 2) Patients with a history of ustekinumab 3) Patients with previous colorectal surgery 4) Patients with serious infections 5) Patients with active tuberculosis 6) Patients with a history of hypersensitivity to any of the ingredients in ustekinumab 7) Patients undergoing treatment for malignancy 8) Patients who are pregnant at the start of treatment 9) Patients deemed ineligible by the attending physician

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath